206 related articles for article (PubMed ID: 26918601)
1. Comprehensive analysis of lncRNA expression profiles and identification of functional lncRNAs in lung adenocarcinoma.
Qiu M; Feng D; Zhang H; Xia W; Xu Y; Wang J; Dong G; Zhang Y; Yin R; Xu L
Oncotarget; 2016 Mar; 7(13):16012-22. PubMed ID: 26918601
[TBL] [Abstract][Full Text] [Related]
2. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
[TBL] [Abstract][Full Text] [Related]
3. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
[TBL] [Abstract][Full Text] [Related]
4. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
[TBL] [Abstract][Full Text] [Related]
5. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
Liu B; Chen Y; Yang J
Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
7. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
[TBL] [Abstract][Full Text] [Related]
8. LncRNA Expression Signature in Prediction of the Prognosis of Lung Adenocarcinoma.
Li L; Feng T; Qu J; Feng N; Wang Y; Ma RN; Li X; Zheng ZJ; Yu H; Qian B
Genet Test Mol Biomarkers; 2018 Jan; 22(1):20-28. PubMed ID: 29297704
[TBL] [Abstract][Full Text] [Related]
9. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27.
Qiu M; Xu Y; Wang J; Zhang E; Sun M; Zheng Y; Li M; Xia W; Feng D; Yin R; Xu L
Cell Death Dis; 2015 Aug; 6(8):e1858. PubMed ID: 26291312
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
[TBL] [Abstract][Full Text] [Related]
11. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma.
Liang R; Xiao G; Wang M; Li X; Li Y; Hui Z; Sun X; Qin S; Zhang B; Du N; Liu D; Ren H
Biomed Pharmacother; 2018 Nov; 107():1434-1446. PubMed ID: 30257360
[TBL] [Abstract][Full Text] [Related]
12. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
Chen M; Liu B; Xiao J; Yang Y; Zhang Y
Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330
[TBL] [Abstract][Full Text] [Related]
13. Identification of key long non-coding RNAs as competing endogenous RNAs for miRNA-mRNA in lung adenocarcinoma.
Li DS; Ainiwaer JL; Sheyhiding I; Zhang Z; Zhang LW
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2285-95. PubMed ID: 27338053
[TBL] [Abstract][Full Text] [Related]
14. Identification of biomarkers for the detection of early stage lung adenocarcinoma by microarray profiling of long noncoding RNAs.
Wang P; Lu S; Mao H; Bai Y; Ma T; Cheng Z; Zhang H; Jin Q; Zhao J; Mao H
Lung Cancer; 2015 May; 88(2):147-53. PubMed ID: 25758555
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of lung adenocarcinoma: A potential four-long noncoding RNA prognostic signature.
Sui J; Yang S; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
J Cell Biochem; 2019 Jan; 120(1):705-714. PubMed ID: 30125988
[TBL] [Abstract][Full Text] [Related]
16. Detection and Analysis of Wnt Pathway Related lncRNAs Expression Profile in Lung Adenocarcinoma.
Chen J; Hu L; Chen J; Pan Q; Ding H; Xu G; Zhu P; Wen X; Huang K; Wang Y
Pathol Oncol Res; 2016 Jul; 22(3):609-15. PubMed ID: 26857641
[TBL] [Abstract][Full Text] [Related]
17. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p.
Dong HX; Wang R; Jin XY; Zeng J; Pan J
J Cell Physiol; 2018 May; 233(5):4126-4136. PubMed ID: 29030962
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of lncRNA and mRNA Expression Profiles in Lung Cancer.
Chen R; Li WX; Sun Y; Duan Y; Li Q; Zhang AX; Hu JL; Wang YM; Gao YD
Clin Lab; 2017 Feb; 63(2):313-320. PubMed ID: 28182363
[TBL] [Abstract][Full Text] [Related]
19. Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma.
Lv W; Yu X; Li W; Feng N; Feng T; Wang Y; Lin H; Qian B
Oncol Rep; 2018 Nov; 40(5):2698-2709. PubMed ID: 30132554
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
